GlassScriptPhysician profile
Andrew H Oh
NPI 1932312766
$30,103.40
in general payments reported to CMS, 2019-2025
36 companies · $1,965 in 2025
The $1,965 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $1,431 · 2021: $3,944 · 2022: $2,325 · 2023: $541 · 2024: $1,199 · 2025: $1,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,533 · Travel and Lodging: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,533.06 |
| Travel and Lodging | $1,172.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $17,560.15 | 2019 | |
| Abbott Laboratories | $3,595.63 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Spinal Simplicity, LLC | $2,229.64 | 2021-2022 | |
| Si-Bone, INC. | $1,527.86 | 2019-2025 | |
| Boston Scientific Corporation | $862.78 | 2019-2021 | |
| Aurora Spine, INC. | $793.20 | 2022 | |
| Relievant Medsystems, INC. | $550.80 | 2021-2022 | |
| Abbvie INC. | $524.06 | 2022-2025 | |
| Vgi Medical, LLC | $444.80 | 2020 | |
| Stimwave Technologies Incorporated | $216.00 | 2019-2021 | |
| Nalu Medical, INC. | $210.98 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $180.22 | 2019-2024 | Belbuca, Xtampza |
| Spinefrontier, INC. | $160.61 | 2020 | |
| Vertos Medical, INC. | $151.53 | 2024 | Mild Device Kit |
| Allergan, INC. | $116.36 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $111.31 | 2019-2022 | |
| Pfizer INC. | $109.05 | 2019-2024 | |
| Grt US Holding, INC. | $85.51 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $74.64 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $71.67 | 2022 | |
| Bioventus LLC | $69.95 | 2024-2025 | Durolane |
| Merz Pharmaceuticals, LLC | $64.87 | 2024-2025 | Xeomin |
| Averitas Pharma INC. | $61.66 | 2023-2025 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $49.57 | 2023 | Iovera |
| Medtronic, INC. | $41.78 | 2024 | Kyphon Express II Kyphopak Tray |
| Teva Pharmaceuticals USA, INC. | $40.97 | 2019-2020 | |
| Saluda Medical Americas, INC. | $29.75 | 2025 | Evoke |
| Biodelivery Sciences International, INC. | $27.71 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $23.21 | 2025 | |
| Globus Medical, INC. | $20.05 | 2025 | Vyrsa V1 |
| Supernus Pharmaceuticals, INC. | $18.01 | 2020 | |
| Lilly USA, LLC | $17.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.92 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.50 | 2019 | |
| Nevro Corp. | $15.00 | 2024 | Senza |
| Arbor Pharmaceuticals, INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.